Onconova Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Onconova Therapeutics (TRAW) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Onconova Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Onconova Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Onconova Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $263 | 263 | 1.00 |
| 2023-12-31 | $7.7k | 7.7k | 1.00 |
| 2023-09-30 | $45 | 63 | 0.71 |
| 2023-06-30 | $6.7k | 5.7k | 1.18 |
| 2023-03-31 | $11k | 15k | 0.73 |
| 2022-12-31 | $9.4k | 15k | 0.65 |
| 2022-09-30 | $0 | 24k | 0.00 |
| 2022-06-30 | $0 | 300 | 0.00 |
| 2022-03-31 | $6.8k | 4.1k | 1.65 |
| 2021-12-31 | $6.0k | 2.4k | 2.47 |
| 2021-09-30 | $16k | 4.1k | 3.94 |
| 2021-06-30 | $25k | 3.9k | 6.44 |